NOVO NORDISK PHARMA OPERATIONS A/S
CVR 32657222 · Public limited company (A/S) · Active · Low risk
NOVO NORDISK PHARMA OPERATIONS A/S is a Public limited company (A/S), founded on , based in Bagsværd. The company is registered in the industry formidlingsaktiviteter i forbindelse med specialiserede bygge- og anlægsarbejder. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 16 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 33.4m and a net result of DKK 2.0m.
Bankruptcy risk for NOVO NORDISK PHARMA OPERATIONS A/S
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32657222
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (16 years)
- Address
- c/o Novo Nordisk A/S, Novo Alle 1
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Formidlingsaktiviteter i forbindelse med specialiserede bygge- og anlægsarbejder (436000)
Bankruptcies in the industry: Kombinerede administrationsserviceydelser - Share capital
- DKK 500k
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 16 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 36.3% |
| Current ratio | 169% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 13 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 126.2m | DKK 109.6m |
| Gross profit | DKK 5.0m | DKK 3.1m |
| Net profit | DKK 2.0m | DKK 2.3m |
| Equity | DKK 33.4m | DKK 31.2m |
| Total assets | DKK 92.2m | DKK 87.6m |
| Cash | DKK 14.1m | – |
| Short-term debt | DKK 45.0m | – |
| Tax owed | DKK 619k | – |
| Avg. employees | 103 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Auditor's report on audited financial statements · DeloitteStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 159 | ||
| 1 Jan 2024 – 31 Dec 2024 | 153 | ||
| 1 Jan 2023 – 31 Dec 2023 | 156 | ||
| 1 Jan 2022 – 31 Dec 2022 | 151 | ||
| 1 Jan 2021 – 31 Dec 2021 | 144 | ||
| 1 Jan 2020 – 31 Dec 2020 | 145 | ||
| 1 Jan 2019 – 31 Dec 2019 | 150 | ||
| 1 Jan 2018 – 31 Dec 2018 | 147 | ||
| 1 Jan 2017 – 31 Dec 2017 | 135 | ||
| 1 Jan 2016 – 31 Dec 2016 | 129 | ||
| 1 Jan 2015 – 31 Dec 2015 | 131 | ||
| 1 Jan 2014 – 31 Dec 2014 | 112 | ||
| 1 Jan 2013 – 31 Dec 2013 | 132 | ||
| 1 Jan 2012 – 31 Dec 2012 | 129 | ||
| 1 Jan 2011 – 31 Dec 2011 | 151 | ||
| 18 Dec 2009 – 31 Dec 2010 | 131 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Leif Fenger Jensen | ||
| CEO | Peter Helt Jacobsen Haahr | ||
| Board | Linette Tangsgaard Nielsen | Current | |
| Board | Lars Bo Smidt | Current | |
| Board | Thomas Rask Nielsen | Current | |
| Board | Ole Falvig Ramsby | ||
| Board | Lars Green | ||
| Board | Robert Janicki | ||
| Board | Karsten Munk Knudsen | ||
| Board | Anne Mette Wiis Vogelsang | ||
| Board | Claus Steensen Sølje | ||
| Board | Lene Moth Bang | ||
| Board | Tomas Haagen | ||
| Board | Kristine Aachmann Bethe | ||
| Board | John Francis Kuckelman | ||
| Owner (100%) | NOVO NORDISK REGION AAMEO AND LATAM A/S | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | GORRISSEN FEDERSPIEL KOMPLEMENTAR ADVOKATANPARTSSELSKAB | Current |
The CEOs' other companies
Leif Fenger Jensen – 2 other companies
- BDT - MiljøRådgivning ApS Active
- Sasibel Holding ApS Active
Peter Helt Jacobsen Haahr – 20 other companies
- Altasciences Holdco A/S Active
- Availity HoldCo A/S Opløst
- BBI HoldCo A/S Active
- ENV HoldCo A/S Opløst
- ERT HoldCo A/S Active
- FONDSMÆGLERSELSKABET STOCKRATE ASSET MANAGEMENT A/S Active
- K. E. KRISTENSEN OG JØRN HAAHR FINANS A/S Opløst
- Komplementarselskabet Novo Capital Investors ApS Active
- LEO PHARMA A/S Active
- LH Capital A/S Active
- Lars Haahr A/S Active
- NNIT A/S Active
- Novo Holdings A/S Active
- Novo Invest 1 A/S Opløst
- Novo Invest 2A A/S Active
- Novo Nordisk Pharmatech A/S Active
- SONION HOLDCO A/S Active
- Servier Symphogen A/S Active
- VEA ApS Active
- XELLIA HOLDCO A/S Active
Address history (1 moves)
| c/o Novo Nordisk A/S, Novo Alle 1, 2880 Bagsværd | |
| Novo Alle 1, 2880 Bagsværd |
Other companies at the same address
- NOVO NORDISK A/S Active
- NOVO NORDISK FARMAKA DANMARK A/S Opløst
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 1 A/S Opløst
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- NOVO NORDISK SECURITY A/S Opløst
- Novo Nordisk Invest 4 A/S Active
- Novo Nordisk North America Operations A/S Active
Similar companies in Gladsaxe
- Den Interne Eksterne ApS Kongens Lyngby
- Eventyrevent ApS Bagsværd
- SL Pro ApS Søborg
- Tower14 ApS Søborg
- Plast-IQ ApS Søborg
- Blomster - Frk. From ApS Søborg
- Tower77 ApS Søborg
- Service Resources & Global Supply ApS Søborg
- JBC VVS ApS Søborg
- PA/PF af 2018 ApS Søborg
- JTK MULTISERVICE ApS Søborg
- FESTIVALGEAR ApS Kongens Lyngby
Questions and answers about NOVO NORDISK PHARMA OPERATIONS A/S
Has NOVO NORDISK PHARMA OPERATIONS A/S gone bankrupt?
No, NOVO NORDISK PHARMA OPERATIONS A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of NOVO NORDISK PHARMA OPERATIONS A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of NOVO NORDISK PHARMA OPERATIONS A/S?
NOVO NORDISK PHARMA OPERATIONS A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was NOVO NORDISK PHARMA OPERATIONS A/S founded?
NOVO NORDISK PHARMA OPERATIONS A/S was founded on 18 December 2009.
What is the equity of NOVO NORDISK PHARMA OPERATIONS A/S?
Equity was DKK 33.4m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.